Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $13,186 - $15,735
-272 Reduced 5.76%
4,452 $228,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $435,853 - $487,352
-7,529 Reduced 61.45%
4,724 $274,000
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $830,141 - $921,742
-13,030 Reduced 51.54%
12,253 $783,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1.33 Million - $1.51 Million
-20,304 Reduced 44.54%
25,283 $1.75 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $743,281 - $880,150
10,854 Added 31.25%
45,587 $3.28 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2,006 - $1.19 Million
-15,435 Reduced 30.77%
34,733 $2.47 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $814,360 - $896,895
-11,214 Reduced 18.27%
50,168 $3.86 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $85,518 - $102,544
-1,391 Reduced 2.22%
61,382 $4.48 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $2.59 Million - $3.02 Million
48,296 Added 333.61%
62,773 $3.91 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $78,518 - $91,974
1,327 Added 10.09%
14,477 $856,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $52,252 - $56,902
844 Added 6.86%
13,150 $878,000
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $99,275 - $111,656
1,673 Added 15.73%
12,306 $776,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $499,104 - $565,576
8,644 Added 434.59%
10,633 $659,000
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $38,822 - $43,020
-676 Reduced 25.37%
1,989 $120,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $3,234 - $3,781
-59 Reduced 2.17%
2,665 $157,000
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $55,308 - $80,376
-1,192 Reduced 30.44%
2,724 $152,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $93,400 - $121,832
1,898 Added 94.05%
3,916 $251,000
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $7,826 - $9,279
183 Added 9.97%
2,018 $102,000
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $81,877 - $90,538
1,835 New
1,835 $83,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mirova Portfolio

Follow Mirova and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.